Cortechs.ai | NeuroQuant

Brain segmentation and volumetric analysis for patients with neurodegenerative diseases

Our cloud-based AI software is designed to segment, quantify, and compare brain structure volume for neurodegenerative disease. NeuroQuant® integrates seamlessly into radiology workflows and can adapt data outputs to meet your practice’s unique needs.
Cortechs.ai|NeuroQuant
Cortechs.ai|NeuroQuant
Cortechs.ai|NeuroQuant

Identify and assess neurodegeneration in its earliest stages

Deliver the best treatment and lifestyle planning for patients by supporting your clinical impression with objective, volumetric data and color-coded brain structure analysis. With NeuroQuant®, you can increase diagnostic accuracy and reduce variability between readers.

Benefits

Cortechs.ai|NeuroQuant

Change visualization

Use high-resolution 3D T1 images to detect subtle changes in ventricle expansion, tissue atrophy, and swelling.

Cortechs.ai|NeuroQuant

Longitudinal disease tracking

Monitor structure volumes and visually evaluate changes using color-coded overlays and change quantification data.

Cortechs.ai|NeuroQuant

Normative reference data

Compare the patient’s brain structure volume measurements to a normal population.

Cortechs.ai|NeuroQuant

Accuracy across all ages

Analyze ages 3-100 using our Dynamic Atlas™ technology, validated over thousands of clinical cases.

Cortechs.ai|NeuroQuant

Adaptable data outputs

Tailor solutions for a broad spectrum of neurological disorders, including MS, Alzheimer’s Disease, epilepsy, microvascular ischemic disease, TBI, and ARIA.

NeuroQuant® reports

Clinically-focused reports provide precise and detailed volumetric data for the clinical assessment of brain disorders.

Cortechs.ai|NeuroQuant

Understanding CPT Codes 0865T & 0866T

As of January 1, 2024, new Category III CPT codes (0865T, 0866T) are active for AI-assisted quantitative brain MRI analysis. These codes apply to a variety of vendor solutions, including Cortechs.ai, and serve as an essential step toward achieving permanent reimbursement.

Related insights

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.

11/17/2025

Unlocking the Value of NeuroQuant Reports: Different Use Cases Across Clinical Practice

From neurodegeneration and demyelination to development, trauma, and seizures, NeuroQuant supports better decision‑making, communication, and patient care

11/04/2025

NeuroQuant Dementia in Different Use Cases 

NeuroQuant transforms brain imaging into a measurable biomarker for neurodegeneration by combining volumetric data with clinical expertise.
Scroll to Top